Treatment of non-Hodgkin's lymphoma in the elderly: An update

Hematological Oncology

Volumn 16, Issue 1, 1998, Pages 1-13

  Tirelli, Umberto ^a   Zagonel, Vittorina ^a   Errante, Domenico ^a   Fratino, Lucia ^a   Monfardini, Silvio ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE; VINCRISTINE SULFATE;

AGE; AGED; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; CANCER CARE FACILITIES; CLINICAL TRIALS; HUMANS; ITALY; LYMPHOMA, NON-HODGKIN; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES;

EID: 0031790689     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(1998030)16:1<1::AID-HON617>3.0.CO;2-7     Document Type: Review

References (46)

1. Dixon, D. O., Neilan, B., Jones, S. E., et al. Effect of age on therapeutic outcome in advanced diffuse histocytic lymphoma: the Southwest Oncology Group Experience. J. Clin. Oncol. 1986, 4, 295-305.
2. Solal-Celigny, P., Chastang, C., Herrera, A., et al. Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma. Am. J. Med. 1987, 83, 1075-1079.
3. Vose, J. M., Armitage, J. O., Weisenburger, D. D., et al. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J. Clin. Oncol. 1988, 6, 1838-1844.
4. Shipp, M. A., Harrington, D. P., Anderson, J. R., et al. A predictive model for aggressive NHL: the International Non-Hodgkin's Lymphoma Prognostic Factors Project. New Eng. J. Med. 1993, 329, 987-994.
5. National Cancer Institute Update. Annual Cancer Statistics Update, December 8. Bethesda, MA: National Cancer Institute, 1986.
6. Holmes, F. F. Clinical evidence for change in tumor aggressiveness with age. In: Balducci, L., Lyman, G. H., Ershler, W. B., eds. Geriatric Oncology. Philadelphia, PA: Lippincott, 1992: 86-91.
7. Carbone, A., Volpe, R., Gloghini, A., et al. Non-Hodgkin's lymphoma in the elderly: 1. Pathologic features at presentation. Cancer 1990, 66, 1991-1994.
8. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphoma. Summary and description of a working formulation for clinical usage. Cancer 1982, 49, 2112-2135.
9. Ballester, O. F., Moscinski, L., Spiers, A., Balducci, L. Non-Hodgkin's lymphoma in the older person: a review. J Am. Geriatr. Soc. 1993, 41, 1245-1254.
10. Phuphanich, S., Werner, M., Lyman, G. Increasing incidence of primary central nervous system lymphoma (PCNSL) in the elderly: Florida Cancer Data Systems (FCDS). Proc. Am. Soc. Clin. Oncol. 1995, 14, 185 (Abstr.).
11. Tirelli, U., Zagonel, V., Serraino, D., et al. Non-Hodgkin's lymphoma in 137 patients aged 70 years or older. A retrospective European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group Study. J. Clin. Oncol. 1988, 6, 1708-1713.
12. Armitage, J. O., Potter, J. F. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly. Increased complications of advancing age. J. Am. Geriatr. Soc. 1984, 32, 269-273.
13. O'Connell, J. D., Harrington, D. P., Johnson, G. J., et al. Initial chemotherapy doses for elderly patients with malignant lymphoma. J. Clin. Oncol. 1986, 4, 1418 (letter).
14. Orlandi, E., Lazzarino, M., Brusamolino, E., et al. Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results. Hematologica 1991, 76, 204-208.
15. Neilly, I. J., Ogston, M., Bennett, B., et al. High grade non-Hodgkin's lymphoma in the elderly-12 year experience in the Grampian region of Scotland. Hematol. Oncol. 1995, 13, 99-106.
16. D'Amore, F., Brincker, H., Christensen, B. E., et al. for the Danish LYFO Study Group. Non-Hodgkin's lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry. Ann. Oncol. 1992, 3, 379-386.
17. Grogan, L., Corbally, N., Dervan, P. A. Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose adriamycin-based regimen. Ann. Oncol. 1994, 5 (S2), 47-51.
18. O'Reilly, S. E., Klimo, P., Connors, J. M. Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma. J Clin. Oncol. 1991, 9, 741-747.
19. O'Reilly, S. E., Connors, J. M., Howdle, S., et al. In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy. J. Clin. Oncol. 1993, 11, 2250-2257.
20. Kitamura, K., Takaku, F. Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly. Am. J. Clin. Oncol. 1990, 13(Suppl. 1), S15-S19.
21. McMaster, M. L., Johnson, D. H., Greer, J. P., et al. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma. Cancer 1991, 67, 1487-1492.
22. Sonneveld, P., Michiels, J. J. Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen. Br. J. Cancer 1990, 62, 105-108.
23. Salvagno, L., Contu, A., Fiorentino, M. V., et al. A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma. Ann. Oncol. 1992, 3, 833-837.
24. Ansell, S. M., Falkson, G. A phase II trial of a chemotherapy combination in elderly patients with aggressive lymphoma. Ann. Oncol. 1993, 4, 172-175 (letter).
25. Hainsworth, J. D. Chronic administration of etoposide in the treatment of non-Hodgkin's lymphoma. Leuk. Lymph. 1993, 10, 65-72.
26. Goss, P., Burkes, R., Rudinskas, L., et al. A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patients. Leuk. Lymph. 1995, 18, 145-152.
27. Tigaud, J. D., Demolombe, S., Coiffier, B. Ifosfamide continuous infusion plus etoposide in the treatment of elderly patients with aggressive lymphoma: a phase II study. Hematol. Oncol. 1991, 9, 225-233.
28. Liang, R., Todd, D., Chan, T. K. COPP therapy for elderly patients with intermediate and high grade non-Hodgkin's lymphoma. Hematol. Oncol. 1993, 2, 43-50.
29. Zinzani, P. L., Bendani, M., Gherlinzoni, F. VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly. Haematologica 1993, 78, 378-382.
30. Bessel, E. M., Coutts, A., Fletcher, J., et al. Non-Hodgkin's lymphoma in the elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology. Eur. J. Cancer 1994. 30A, 1337-1341.
31. Martelli, M., Guglielmi, C., Coluzzi, S., et al. P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma. J. Clin. Oncol. 1993, 11, 2362-2369.
32. Caracciolo, F., Petrini, M., Capochiani, E., et al. Third generation chemotherapy with P-VABEC for aggressive non-Hodgkin's lymphomas in the elderly. Leuk. Lymph. 1993, 11, 115-118.
33. Bertini, M., Freilone, R., Vitolo, U., et al. P-VEBEC: A new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma. Ann. Oncol. 1994, 5, 895-900.
34. Young, A. W., Greco, F. A., Greer, J. P., Hainsworth, J. D. Aggressive non-Hodgkin's lymphoma in the elderly: Treatment regimen containing extended schedule etoposide. J. Natl. Cancer Inst. 1994, 86, 1346-1347.
35. Meyer, R. M., Browman, G. P., Samosh, M. L., et al. Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma. J. Clin. Oncol. 1995, 13, 2386-2393.
36. Sonneveld, P., de Ridder, M., van der Lelie, H., et al. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. J. Clin. Oncol. 1995, 13, 2530-2539.
37. Bastion, Y., Blay, J.-Y., Divine, M., et al. Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival - A Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years. J. Clin. Oncol. 1997, 15, 2945-2953.
38. Guerci, A., Lederlin, P., Reyes, F., et al. Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Ann. Oncol. 1996, 7, 966-969.
39. Zagonel, V., Carbone, A., Kerpel-Fronius, S., et al. Management of non-Hodgkin's lymphomas in the elderly patients: conclusions of the Second Intercity Meeting of the European School of Oncology (ESO), 1987. In: Monfardini, S., ed. The Management of Non-Hodgkin's Lymphomas in Europe. Berlin, Germany: Springer-Verlag, 1990: 35-44.
40. Tirelli, U., Carbone, A., Crivellari, D., et al. A phase II trial of teniposide (VM26) in advanced non-Hodgkin's lymphoma with emphasis on the treatment of elderly patients. Cancer 1984, 54, 393-396.
41. Tirelli, U., Carbone, A., Zagonel, V., Veronesi, A., Canetta, R. Non-Hodgkin's lymphomas in the elderly. Prospective studies with specifically devised chemotherapy regimens in 66 patients. Eur. J. Cancer Clin. Oncol. 1987, 23, 535-540.
42. Zagonel, V., Tirelli, U., Carbone, A., et al. Combination chemotherapy specifically devised for elderly patients with unfavourable non-Hodgkin's lymphoma. Cancer Invest. 1990, 8, 575-580.
43. Tirelli, U., Zagonel, V., Errante, D., et al. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavourable non-Hodgkin's lymphoma. J. Clin. Oncol. 1992, 10, 228-236.
44. Tirelli, U., Errante, D., Van Glabbeke, M., et al. CHOP is the standard regimen in patients ≥ 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J. Clin. Oncol. 1998, 16, 27-34.
45. Monfardini, S., Sacco, C., Serraino, D., et al. Effects of G-CSF in patients with Non-Hodgkin's Lymphomas (NHL) older than 70 years. Ann. Oncol. 1996, 7 (Suppl. 3), 164 (Abstr. no. 611).
46. Zagonel, V., Babare, R., Merola, M. C., et al. Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy. Ann. Oncol. 1994, 5 (Suppl. 2), S127-S132.